**[Fortune: MEI Pharma and Several Other Companies Experience Unusual Stock Price Surge Ahead of Crypto Treasury Announcements, Suspected Insider Trading]** Foresight News reports, according to Fortune magazine, that anti-cancer drug developer MEI Pharma saw its stock price nearly double in mid-July this year, just days before announcing its $100 million crypto treasury strategy. This occurred despite the company not filing any major updates with the U.S. Securities and Exchange Commission, releasing no press statements, and generating almost no discussion on social media. MEI Pharma is not the only company whose stock price experienced unusual surges prior to announcing cryptocurrency purchase strategies. Fortune magazine identified similar patterns in other small publicly traded companies. According to finance professors, investors, and corporate CEOs, this suggests that insiders may have had early access to certain announcements. "In my view, this is indeed suspicious," said Xu Jiang, a Duke University professor who researches insider trading in public markets. "As far as I know, many cases of insider trading look like this." He added that without a thorough investigation, he could not confirm whether insider trading had occurred. MEI Pharma's spokesperson declined to comment. Spokespersons for four other companies—Kindly MD, Empery Digital, Fundamental Global, and 180 Life Sciences Corp—whose stock prices also experienced unusual fluctuations prior to cryptocurrency purchases, did not respond to requests for comment. Similarly, representatives from two cryptocurrency asset management companies, VivoPower and Sonnet BioTherapeutics, whose stock prices exhibited similar volatility, also declined to comment. However, some of those who benefited from the price increases related to cryptocurrency announcements were not retail investors but individuals connected to the companies or external parties with access to private information. These individuals appear to have profited by acting ahead of the news. For example, ETH treasury company SharpLink saw its stock price more than double—from $3 to $6—during the three trading days leading up to its announcement, despite not filing documents with the SEC or issuing press releases. "There was definitely a leak because they engaged too many investors, making it difficult to control," said the CEO of another cryptocurrency fund management company involved in the transactions. This executive declined to disclose their identity when discussing competitors.